Milestone Scientific Inc

MLSS
0,56
-0,01 (-1,75%)
26 Apr 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: AMEX
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
03/4/202414:30GLOBEMilestone Scientific Commences Sales of CompuFlo® Epidural..
01/4/202413:00GLOBEMilestone Scientific Achieves 12% Increase in Revenue and..
28/3/202416:45GLOBEMilestone Scientific Schedules 2023 Year-End Financial..
14/3/202413:30GLOBEMilestone Scientific Commences Sales of CompuFlo® Epidural..
28/2/202414:30GLOBEMilestone Scientific Commences Direct Sales of STA Single..
20/2/202414:30GLOBEMilestone Scientific Commences Direct Sales of STA Single..
16/1/202414:30GLOBEMilestone Scientific CEO Provides Letter to Shareholders;..
12/1/202422:34EDGAR2Form 8-K - Current report
13/12/202323:00GLOBEMilestone Scientific Inc. Announces Closing of $3.0 Million..
13/12/202318:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202323:21EDGAR2Form 8-K - Current report
12/12/202323:10EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/12/202302:33GLOBEMilestone Scientific Inc. Announces Pricing of $3.0 Million..
08/12/202322:03GLOBEMilestone Scientific Inc. Announces Proposed Public Offering..
08/12/202322:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
08/12/202314:30GLOBEMilestone Scientific Commences Sales of CompuFlo® ..
28/11/202314:30GLOBEMilestone Announces Agreement with Bioline Supply to..
15/11/202313:00GLOBEMilestone Scientific Achieves Revenue of $2.1 Million and..
10/11/202314:30GLOBEMilestone Scientific Schedules Third Quarter 2023 Financial..
09/11/202314:30GLOBEMilestone Scientific Commences Sales of CompuFlo® Epidural..
31/10/202305:15EDGAR2Form EFFECT - Notice of Effectiveness
23/10/202323:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/10/202323:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/10/202320:36EDGAR2Form S-3 - Registration statement under Securities Act of..
17/10/202322:03EDGAR2Form 144 - Report of proposed sale of securities
12/9/202317:00GLOBEMilestone Scientific Appoints Pain Management Industry..
12/9/202315:46EDGAR2Form 8-K - Current report
24/8/202322:51EDGAR2Form 8-K - Current report
15/8/202313:00GLOBEMilestone Scientific Achieves 77% Year-Over-Year Increase in..
14/8/202322:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/8/202301:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202301:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202300:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202322:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202322:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202322:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202322:05GLOBEMilestone Scientific Schedules Second Quarter 2023 Financial..
09/8/202314:30GLOBEMilestone Scientific Announces Positive Insurance Payment..
13/7/202321:02EDGAR2Form S-8 - Securities to be offered to employees in employee..
13/7/202316:11EDGAR2Form 8-K - Current report
30/6/202322:00EDGAR2Form 8-K - Current report
15/6/202317:00GLOBEMilestone Scientific to Present at the Maxim Group Virtual..
16/5/202314:30GLOBEMilestone Scientific Commences Sales of CompuFlo® Epidural..
11/5/202313:00GLOBEMilestone Scientific Achieves Revenue of $2.6 Million..
10/5/202314:30GLOBEMilestone Scientific Announces Successful Epidural Steroid..
09/5/202314:30GLOBEMilestone Scientific Commences Sales of CompuFlo® Epidural..
05/5/202317:00GLOBEMilestone Scientific Schedules First Quarter 2023 Financial..
Apertura: 0,58 Min: 0,55 Max: 0,59
Chiusura: 0,57

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network